Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China · Delayed Price · Currency is CNY 35.25
-0.05 (-0.14%)
Apr 29, 2026, 3:04 PM CST
SHE:300683 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -244.55 | -235.43 | -69.35 | -120.82 | -14.03 | 27.65 |
Depreciation & Amortization | 97.35 | 97.35 | 91.14 | 71.07 | 53.47 | 37.91 |
Other Amortization | 2.49 | 2.49 | 5.24 | 1.66 | 0.78 | 0.8 |
Loss (Gain) From Sale of Assets | 0.98 | 0.98 | 0.07 | 0.36 | 0.09 | 0.18 |
Asset Writedown & Restructuring Costs | 135.46 | 135.46 | 1.15 | 42.59 | 17.22 | 0.02 |
Loss (Gain) From Sale of Investments | -20.64 | -20.64 | -6.48 | -17.58 | -23.72 | -14.01 |
Provision & Write-off of Bad Debts | - | - | 9.46 | -4.24 | 15.85 | 13.38 |
Other Operating Activities | 59.29 | 2.89 | 7.76 | 20.07 | 11.24 | 2.93 |
Change in Accounts Receivable | -8.71 | -8.71 | -51.76 | 24.42 | 13.49 | -67.5 |
Change in Inventory | 12.38 | 12.38 | -1.53 | -21.9 | -52.45 | -0.75 |
Change in Accounts Payable | -59.33 | -59.33 | 49.21 | 35.19 | 34.18 | 26.17 |
Operating Cash Flow | -29.26 | -76.54 | 22.69 | 5.31 | 53.03 | 12.09 |
Operating Cash Flow Growth | - | - | 326.89% | -89.98% | 338.72% | - |
Capital Expenditures | -48.99 | -50.54 | -43.08 | -167.44 | -173.97 | -247.11 |
Sale of Property, Plant & Equipment | 1.85 | 1.37 | 0.02 | 2.07 | 0.02 | 0.02 |
Cash Acquisitions | - | - | - | - | -22.72 | -197 |
Divestitures | - | - | - | - | 3 | 4.28 |
Investment in Securities | 177.54 | 370.21 | -70.09 | -345.86 | 704.01 | -528.15 |
Other Investing Activities | 12.55 | 11.88 | 12.8 | 19.3 | 15.02 | 14.96 |
Investing Cash Flow | 142.96 | 332.92 | -100.35 | -491.93 | 525.36 | -953.01 |
Long-Term Debt Issued | - | - | - | 10 | - | 84.97 |
Long-Term Debt Repaid | - | -4.96 | -18.52 | -49.09 | -8.06 | -8.34 |
Net Debt Issued (Repaid) | -3.67 | -4.96 | -18.52 | -39.09 | -8.06 | 76.63 |
Issuance of Common Stock | - | - | - | 290 | - | 589.97 |
Common Dividends Paid | -0.56 | -17.87 | -1.76 | -2.2 | -1.34 | -0.06 |
Other Financing Activities | -7.9 | -4.42 | 6.85 | -0.42 | -2.89 | -3.72 |
Financing Cash Flow | -12.13 | -27.26 | -13.43 | 248.29 | -12.29 | 662.82 |
Foreign Exchange Rate Adjustments | -0.02 | -0 | 0.04 | 0.01 | 0.05 | -0.04 |
Net Cash Flow | 101.55 | 229.12 | -91.04 | -238.31 | 566.15 | -278.15 |
Free Cash Flow | -78.25 | -127.07 | -20.39 | -162.13 | -120.94 | -235.02 |
Free Cash Flow Margin | -14.39% | -23.47% | -3.14% | -26.92% | -17.56% | -38.23% |
Free Cash Flow Per Share | -0.60 | -0.97 | -0.16 | -1.25 | -0.95 | -2.21 |
Cash Interest Paid | - | - | 0 | 0 | 0.31 | - |
Cash Income Tax Paid | 23.01 | 23.48 | 27.88 | -9.15 | 9.34 | 20.24 |
Levered Free Cash Flow | -385.85 | -99.09 | -37.93 | -100.86 | -122.1 | -430.98 |
Unlevered Free Cash Flow | -385.85 | -99.09 | -36.49 | -99.36 | -121.4 | -430.67 |
Change in Working Capital | -59.63 | -59.63 | -16.29 | 12.2 | -7.88 | -56.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.